Henry Schein, Inc. (NASDAQ:HSIC) Receives $81.10 Average Target Price from Analysts

Shares of Henry Schein, Inc. (NASDAQ:HSIC) have received an average recommendation of “Moderate Buy” from the eleven research firms that are presently covering the company, Marketbeat Ratings reports. Five equities research analysts have rated the stock with a hold rating, five have given a buy rating and one has issued a strong buy rating on the company. The average 12-month price objective among brokerages that have issued ratings on the stock in the last year is $81.10.

HSIC has been the topic of several research analyst reports. Barrington Research reissued an “outperform” rating and set a $90.00 target price on shares of Henry Schein in a research note on Wednesday, February 26th. Mizuho started coverage on shares of Henry Schein in a research report on Wednesday, December 4th. They set a “neutral” rating and a $75.00 price objective on the stock. Bank of America raised Henry Schein from an “underperform” rating to a “buy” rating and boosted their target price for the company from $69.00 to $84.00 in a research report on Monday, January 6th. UBS Group cut their price target on Henry Schein from $83.00 to $80.00 and set a “neutral” rating on the stock in a report on Wednesday, February 26th. Finally, Jefferies Financial Group boosted their price objective on Henry Schein from $77.00 to $80.00 and gave the company a “hold” rating in a report on Thursday, January 23rd.

Insider Activity at Henry Schein

In other news, Director Philip A. Laskawy sold 2,604 shares of the company’s stock in a transaction on Wednesday, March 19th. The shares were sold at an average price of $71.04, for a total value of $184,988.16. Following the completion of the sale, the director now owns 24,805 shares in the company, valued at $1,762,147.20. This represents a 9.50 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, CEO Bradford C. Connett sold 4,036 shares of the stock in a transaction dated Wednesday, March 19th. The shares were sold at an average price of $71.15, for a total transaction of $287,161.40. Following the completion of the sale, the chief executive officer now owns 62,688 shares of the company’s stock, valued at approximately $4,460,251.20. This represents a 6.05 % decrease in their position. The disclosure for this sale can be found here. 1.14% of the stock is currently owned by insiders.

Institutional Trading of Henry Schein

Institutional investors and hedge funds have recently modified their holdings of the business. Invesco Ltd. increased its position in shares of Henry Schein by 0.4% during the 4th quarter. Invesco Ltd. now owns 4,963,409 shares of the company’s stock valued at $343,468,000 after purchasing an additional 17,552 shares during the last quarter. FMR LLC grew its position in Henry Schein by 6.6% during the fourth quarter. FMR LLC now owns 3,498,033 shares of the company’s stock valued at $242,064,000 after buying an additional 217,143 shares during the period. Geode Capital Management LLC increased its holdings in Henry Schein by 0.5% during the fourth quarter. Geode Capital Management LLC now owns 3,169,033 shares of the company’s stock worth $218,762,000 after buying an additional 14,876 shares during the last quarter. Palestra Capital Management LLC bought a new stake in Henry Schein in the fourth quarter worth about $182,988,000. Finally, Southpoint Capital Advisors LP boosted its stake in Henry Schein by 30.0% in the third quarter. Southpoint Capital Advisors LP now owns 2,600,000 shares of the company’s stock valued at $189,540,000 after acquiring an additional 600,000 shares during the last quarter. 96.62% of the stock is owned by hedge funds and other institutional investors.

Henry Schein Stock Up 0.3 %

Shares of NASDAQ:HSIC opened at $69.25 on Thursday. Henry Schein has a 1 year low of $63.67 and a 1 year high of $82.49. The company has a debt-to-equity ratio of 0.46, a current ratio of 1.42 and a quick ratio of 0.82. The business’s 50-day moving average is $74.31 and its 200-day moving average is $72.65. The company has a market capitalization of $8.60 billion, a price-to-earnings ratio of 28.50, a P/E/G ratio of 2.13 and a beta of 0.84.

Henry Schein (NASDAQ:HSIC) last issued its quarterly earnings results on Tuesday, February 25th. The company reported $1.19 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.23 by ($0.04). The business had revenue of $3.19 billion during the quarter, compared to analyst estimates of $3.25 billion. Henry Schein had a net margin of 2.51% and a return on equity of 12.90%. Henry Schein’s quarterly revenue was up 5.8% compared to the same quarter last year. During the same period last year, the firm posted $0.66 earnings per share. Equities research analysts predict that Henry Schein will post 4.74 earnings per share for the current year.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.